Living kidney donor evaluation for all candidates with normal estimated GFR for age
Author(s) -
Gaillard François,
Jacquemont Lola,
Lazareth Hélène,
Albano Laetitia,
Barrou Benoit,
Bouvier Nicolas,
Buchler Mathias,
TitecaBeauport Dimitri,
Couzi Lionel,
Delahousse Michel,
Ducloux Didier,
Etienne Isabelle,
Frimat Luc,
Garrouste Cyril,
Glotz Denis,
Grimbert Philippe,
Hazzan Marc,
Hertig Alexandre,
Hourmant Maryvonne,
Kamar Nassim,
Le Meur Yann,
Le Quintrec Moglie,
Legendre Christophe,
Moal Valérie,
Moulin Bruno,
Mousson Christiane,
PouteilNoble Claire,
Rieu Philippe,
Ouali Nacera,
Rostaing Lionel,
Thierry Antoine,
Toure Fatouma,
Chemouny Jonathan,
Delanaye Pierre,
Courbebaisse Marie,
Mariat Christophe
Publication year - 2021
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/tri.13870
Subject(s) - medicine , kidney , renal function , population , donation , urology , environmental health , economics , economic growth
Summary Multiple days assessments are frequent for the evaluation of candidates to living kidney donation, combined with an early GFR estimation (eGFR). Living kidney donation is questionable when eGFR is <90 ml/min/1.73 m 2 (KDIGO guidelines) or 80 ml/min/1.73 m 2 (most US centres). However, age‐related GFR decline results in a lower eGFR for older candidates. That may limit the number of older kidney donors. Yet, continuing the screening with a GFR measure increases the number of eligible donors. We hypothesized that in‐depth screening should be proposed to all candidates with a normal eGFR for age. We compared the evolution of eGFR after donation between three groups of predonation eGFR: normal for age ( S age ) higher than 90 or 80 ml/min/1.73 m 2 ( S 90 and S 80, respectively); across three age groups (<45, 45–55, >55 years) in a population of 1825 French living kidney donors with a median follow‐up of 5.9 years. In donors younger than 45, postdonation eGFR, absolute‐ and relative‐eGFR variation were not different between the three groups. For older donors, postdonation eGFR was higher in S 90 than in S 80 or S age but other comparators were identical. Postdonation eGFR slope was comparable between all groups. Our results are in favour of in‐depth screening for all candidates to donation with a normal eGFR for age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom